Head-to-Head

Alnylam Pharmaceuticals, Inc. vs. Eli Lilly & Co.

ALNY

Alnylam Pharmaceuticals, Inc.

$239.36 +0.46%

VS LLY

Eli Lilly & Co.

$1152.44 +1.28%

Eli Lilly & Co. (LLY) comes out ahead, leading on 7 of 9 compared factors.

Size & Scale

ALNYLLY
Market Cap $31.88 billion $1.03 trillion
Revenue (TTM) $4.80 billion $79.67 billion
Net Income (TTM) $733.11 million $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

ALNYLLY
P/E Ratio 44.57 38.69
Price / Book 23.54 30.32
Price / Sales 6.64 12.89

ALNY leads on 2 of 3 valuation factors.

Profitability

ALNYLLY
Net Margin 15.26% 33.53%
Return on Equity 54.14% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

ALNYLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

ALNY and LLY split the dividend factors evenly.

Risk & Sentiment

ALNYLLY
Short Interest 4.32% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: ALNY overview, ALNY financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.